"Biliary Tract Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer in the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.
| Descriptor ID |
D001661
|
| MeSH Number(s) |
C04.588.274.120 C06.130.320 C06.301.120
|
| Concept/Terms |
Biliary Tract Neoplasms- Biliary Tract Neoplasms
- Biliary Tract Neoplasm
- Neoplasm, Biliary Tract
- Neoplasms, Biliary Tract
Biliary Tract Cancer- Biliary Tract Cancer
- Biliary Tract Cancers
- Cancer, Biliary Tract
- Cancers, Biliary Tract
- Cancer of the Biliary Tract
- Cancer of Biliary Tract
|
Below are MeSH descriptors whose meaning is more general than "Biliary Tract Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Biliary Tract Neoplasms".
This graph shows the total number of publications written about "Biliary Tract Neoplasms" by people in this website by year, and whether "Biliary Tract Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 1 |
| 2024 | 2 | 1 | 3 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biliary Tract Neoplasms" by people in Profiles.
-
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer. Clin Cancer Res. 2025 Jan 17; 31(2):387-402.
-
Molecular Profiling of Biliary Tract Cancers in African American and Caucasian Patients. JCO Precis Oncol. 2025 Jan; 9:e2400712.
-
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers. J Clin Oncol. 2025 Feb 10; 43(5):536-544.
-
Real-world treatment patterns, resource utilization and costs in biliary tract cancers in the USA. Future Oncol. 2024; 20(34):2625-2636.
-
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer. Future Oncol. 2024; 20(31):2319-2329.
-
American Society for Gastrointestinal Endoscopy guideline on the role of therapeutic EUS in the management of biliary tract disorders: summary and recommendations. Gastrointest Endosc. 2024 Dec; 100(6):967-979.
-
Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018-2023. Clin Mol Hepatol. 2024 Oct; 30(4):756-770.
-
COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC. Future Oncol. 2024; 20(30):2241-2248.
-
Treatment options for biliary tract cancer: unmet needs, new targets and opportunities from both physicians' and patients' perspectives. Future Oncol. 2024; 20(20):1435-1450.
-
Defining and Refining the Role of Adjuvant Chemoradiation for Biliary Tract Cancers After SWOG 0809. Ann Surg Oncol. 2024 Aug; 31(8):4837-4838.